My Verdict on 5 FTSE Boardroomshttp://www.fool.com/investing/international/2012/08/22/my-verdict-on-5-ftse-boardrooms.aspx Tony Reading
August 22, 2012
LONDON -- Management can make all the difference to a company's success -- and thus its share price.
The best companies are those run by talented and experienced leaders with strong vested interests in the success of the business, held in check by a board with sound financial and business acumen. Some of the worst investments to hold are those run by executives collecting fat rewards as the underlying business goes to pot.
In recent weeks, I've been assessing the boardrooms of companies within the FTSE 100: AstraZeneca (LSE: AZN.L ) , British American Tobacco (LSE: BATS.L ) , Petrofac (LSE: PFC.L ) , Royal Bank of Scotland (LSE: RBS.L ) , and Standard Chartered (LSE: STAN.L ) . Today I am going to summarize my findings for the latest five companies.
Five FTSE boardrooms
Petrofac storms into the lead with 20 out of a possible 25 -- the highest-scoring boardroom I've analyzed so far. The strong executive team is led by two entrepreneurs who have built a 5 billion pound company from virtually nothing, and their success demonstrates the truth of the adage that the proof of the pudding is in the eating. They pay themselves modestly but have massive investments in the company. My only reservation concerns future management succession.
At the very opposite end of the scale is RBS, where progress in turning around the bank has been relatively slow. But more tellingly, only CEO Stephen Hester has any significant investment in shares, and even his 1 million pound stake worth is small beer compared to his remuneration. The general lack of faith the board have in their own shares is in marked contrast to the efforts they have displayed defending management bonuses.
BAT has a very respectable score. Surprisingly, a banking controversy holds it back: Chairman Richard Burrows was chairman of the Bank of Ireland when it collapsed. But it would be hard to fault the performance of the executive team, who all have long tenure with the company.
Benefit of the doubt